Search Results - "Fooks, Katharine"

Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening by Salame, Natasha, Fooks, Katharine, El-Hachem, Nehme, Bikorimana, Jean-Pierre, Mercier, François E., Rafei, Moutih

“…Multi-omic approaches offer an unprecedented overview of the development, plasticity, and resistance of cancer. However, the translation from anti-cancer…”
Get full text

P482: The clinical utility of genome-wide sequencing for rare disease: A multidimensional map by Hayeems, Robin, Venkataramanan, Viji, Fooks, Katharine, MacDonald, Karen, Seeger, Trevor, Hartley, Taila, Bernier, Francois, Boycott, Kym, Marshall, Deborah

Get full text

P477: Barriers and facilitators to implementing genomic medicine: A scoping review of the global landscape by Lee, Whiwon, Yan, Joyce, Fooks, Katharine, Tafler, Abby, Banglorewala, Pooja, Barwick, Melanie, Dobrow, Mark, Friedman, Jan, Marshall, Christian, Hayeems, Robin

Get full text

P547: The clinician-reported Genetic testing Utility InDEX (C-GUIDE): Establishing content validity for a new measure for sequencing-based newborn screening by Luca, Stephanie, Fooks, Katharine, Poole, Elise, Pichini, Amanda, Ziff, Joanna, Stone, Katrina, Xiao, Bowen, Shickh, Salma, Bick, David, Chakraborty, Pranesh, Ungar, Wendy, Hayeems, Robin

Get full text

P873: “If you look for a problem, you’ll find one”: A qualitative study to understand why parents/adult patients decline secondary findings by Hansen, Abigail, Luca, Stephanie, Moran, Olivia, Babul-Hirji, Riyana, Yan, Joyce, Fooks, Katharine, Venkataramanan, Viji, Ungar, Wendy, Hayeems, Robin, Study Team, Secondary Findings, Poole, Elise, Assamad, Daniel, Banglorewala, Pooja, Vermeer, Lydia, Marshall, Christian, Gillespie, Meredith, Szuto, Anna, Chisholm, Caitlin, Stavropoulos, James, Huang, Lijia, Jarinova, Olga, Lau, Lynette, Lee, Whiwon, Badalato, Lauren, Balci, Tugce, Chad, Lauren, Inglese, Cara, Ladouceur, Virginie, Mackley, Michael, Morel, Chantal, Richer, Julie, Tarnopolsky, Mark, Villani, Anita, Zahavich, Laura, Sawyer, Sarah, Mendoza-Londono, Roberto, Somerville, Martin, Boycott, Kym, Ungar, Wendy, Hayeems, Robin

Get full text

P866: Exploring the impact of secondary findings in a cohort of patients and families receiving genome-wide sequencing by Fooks, Katharine, Vermeer, Lydia, Poole, Elise, Luca, Stephanie, Babul-Hirji, Riyana, Chad, Lauren, Chitayat, David, Mackley, Michael, Schwartz, Marci, Ungar, Wendy, Hayeems, Robin, Study Team, Secondary Findings, Yan, Joyce, Hansen, Abigail, Venkataramanan, Viji, Assamad, Daniel, Marshall, Christian, Gillespie, Meredith, Szuto, Anna, Chisholm, Caitlin, Stavropoulos, James, Huang, Lijia, Jarinova, Olga, Lau, Lynette, Lee, Whiwon, Badalato, Lauren, Balci, Tugce, Inglese, Cara, Ladouceur, Virginie Beausejour, Morel, Chantal, Richer, Julie, Tarnopolsky, Mark, Villani, Anita, Zahavich, Laura, Moran, Olivia, Sawyer, Sarah, Mendoza-Londono, Roberto, Somerville, Martin, Boycott, Kym

Get full text

Targeting Eukaryotic Initiation Factor 4A to Improve Response to Chemotherapy in Acute Myeloid Leukemia by Fooks, Katharine

“…Acute myeloid leukemia (AML) is an aggressive hematological cancer characterized by uncontrolled proliferation of myeloid cells blocked in differentiation. AML…”
Get full text

Single-Cell Transcriptomic Profiling of De Novo and Relapsed Acute Myeloid Leukemia Identifies a Leukemic Stemness Program Shared across Diverse Phenotypes by Worme, Samantha, Jessa, Selin, Poon, William, Jankovic, Maja, Vazquez, Gabriela Galicia, Bazinet, Alexandre, Fooks, Katharine, Iasenza, Isabella, Arreba-Tutusaus, Patricia, Eppert, Kolja, Ragoussis, Ioannis, Wang, Yu Chang, Johnson, Nathalie A, Assouline, Sarit E, Kleinman, Claudia L, Mercier, François E

“…Introduction: Relapse remains the major cause of mortality in acute myeloid leukemia (AML). Prior work indicates that a rare subset of leukemic stem cells…”
Get full text

Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study by Hartley, Taila, Marshall, Deborah, Acker, Meryl, Fooks, Katharine, Gillespie, Meredith K., Price, E. Magda, Graham, Ian D., White-Brown, Alexandre, MacKay, Layla, Macdonald, Stella K., Brady, Lauren, Hui, Angela Y., Andrews, Joseph D., Chowdhury, Ashfia, Wall, Erika, Soubry, Élisabeth, Ediae, Grace U., Rojas, Samantha, Assamad, Daniel, Dyment, David, Tarnopolsky, Mark, Sawyer, Sarah L., Chisholm, Caitlin, Lemire, Gabrielle, Amburgey, Kimberly, Lazier, Joanna, Mendoza-Londono, Roberto, Dowling, James J., Balci, Tugce B., Armour, Christine M., Bhola, Priya T., Costain, Gregory, Dupuis, Lucie, Carter, Melissa, Badalato, Lauren, Richer, Julie, Boswell-Patterson, Christie, Kannu, Peter, Cordeiro, Dawn, Warman-Chardon, Jodi, Graham, Gail, Siu, Victoria Mok, Cytrynbaum, Cheryl, Rusnak, Alison, Aul, Ritu B., Yoon, Grace, Gonorazky, Hernan, McNiven, Vanda, Mercimek-Andrews, Saadet, Guerin, Andrea, Deshwar, Ashish R., Marwaha, Ashish, Weksberg, Rosanna, Karp, Natalya, Campbell, Maggie, Al-Qattan, Sarah, Shuen, Andrew Y., Inbar-Feigenberg, Michal, Cohn, Ronald, Szuto, Anna, Inglese, Cara, Poirier, Myriam, Chad, Lauren, Potter, Beth, Boycott, Kym M., Hayeems, Robin, Boycott, Kym, Brudno, Michael, Bernier, Francois, van Karnebeek, Clara, Dyment, David, Kernohan, Kristin, Innes, Micheil, Lamont, Ryan, Parboosingh, Jillian, Marshall, Deborah, Marshall, Christian, Mendoza, Roberto, Dowling, James, Hayeems, Robin, Knoppers, Bartha, Lehman, Anna, Mostafavi, Sara

“…To evaluate the diagnostic utility of publicly funded clinical exome sequencing (ES) for patients with suspected rare genetic diseases. We prospectively…”
Get full text